Groundbreaking Gene Editing Approach Initiates First-in-Human Clinical Trial for X-Linked Chronic Granulomatous Disease
A pioneering collaboration between researchers at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH) has …